logo
AAT Bioquest

HLA-DR antigens-associated invariant chain Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
4-[1-[2-Hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC50410.0 [1]
4-[1-[3-[5-Methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC50950.0 [1]
1-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]-3,4-dihydroquinolin-2-oneIC502000.0 [1]
5-Methyl-4-[1-[3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC502000.0 [1]
6-Chloro-4-[1-[2-hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC501300.0 [1]
4-[1-[2-Hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]pyrido[3,2-b][1,4]oxazin-3-oneIC501300.0 [1]
4-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-5-methyl-1,4-benzoxazin-3-oneIC501600.0 [1]
6-Chloro-1-[1-[2-hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-3,4-dihydroquinazolin-2-oneIC501900.0 [1]
1-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]-6-chloro-3,4-dihydroquinolin-2-oneIC50750.0 [1]
1-[4-(6-Chloro-2,2-dioxo-3,4-dihydro-2lambda6,1,3-benzothiadiazin-1-yl)piperidin-1-yl]-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propan-2-olIC501300.0 [1]
4-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC501800.0 [1]
4-[1-[3-[5-Acetyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC50810.0 [1]
4-[1-[3-[5-Acetyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC501100.0 [1]
4-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-1,4-benzoxazin-3-oneIC501600.0 [1]
1-[1-[2-Hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-3,4-dihydroquinolin-2-oneIC501800.0 [1]
4-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-6-chloro-1,4-benzoxazin-3-oneIC502600.0 [1]
1-[1-[2-Hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-4H-3,1-benzoxazin-2-oneIC501400.0 [1]
4-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]pyrido[3,2-b][1,4]oxazin-3-oneIC50900.0 [1]
1-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]-3,4-dihydroquinazolin-2-oneIC501100.0 [1]
1-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]-6-chloro-3,4-dihydroquinazolin-2-oneIC501500.0 [1]
1-[1-[2-Hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-5H-4,1-benzoxazepin-2-oneIC50930.0 [1]
4-[1-[3-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-2-hydroxypropyl]piperidin-4-yl]-6-chloro-1,4-benzoxazin-3-oneIC504400.0 [1]
1-[1-[2-Hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-3,4-dihydroquinazolin-2-oneIC501400.0 [1]
1-[3-(4-Bromophenyl)-5-methylsulfonyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]-3-[4-(6-chloro-2,2-dioxo-3,4-dihydro-2lambda6,1,3-benzothiadiazin-1-yl)piperidin-1-yl]propan-2-olIC502700.0 [1]
6-Chloro-1-[1-[2-hydroxy-3-[5-methylsulfonyl-3-[4-(trifluoromethyl)phenyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]propyl]piperidin-4-yl]-3,4-dihydroquinolin-2-oneIC50980.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ HLA-DR antigens-associated invariant chain Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Dec2024https://www.aatbio.com/data-sets/hla-dr-antigens-associated-invariant-chain-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024December 21). Quest Database™ HLA-DR antigens-associated invariant chain Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/hla-dr-antigens-associated-invariant-chain-inhibitors-ic50-ki.
BibTeXEndNoteRefMan